Supreme Court Extends Mail Access to Abortion Pill

The Supreme Court stepped into the abortion pill fight at the last minute, preserving access by mail to mifepristone for at least a few more days.

Justice Samuel A. Alito Jr. paused a lower-court ruling that would have restricted how the drug reaches patients, according to the news signal. The order does not settle the legal battle, but it blocks immediate changes while the justices weigh the next move. For now, the Food and Drug Administration’s current framework stays in place.

The court did not end the dispute; it stopped an abrupt shift while the legal fight moves forward.

The case has become a major test of federal authority over drug regulation and abortion access after the end of national abortion protections. A federal appeals court had moved against the FDA in a way that would limit access to mifepristone by mail. That raised the prospect of rapid disruption for patients, providers, and pharmacies that rely on the existing rules.

The justices now face pressure to decide whether to leave the pause in place longer, lift it, or take broader action as the case advances. That decision matters well beyond this one drug: it could shape how courts treat FDA judgments, how medication abortion reaches patients, and how quickly nationwide access can change through emergency orders.